The 2nd Edition of SLAS advanced 3D human models and High-Content Analysis Conference was a great event with interesting presentations and posters from public labs and various companies. In regards of the different presentations, it Read more…
The 20th International Congress on In Vitro Toxicology (ESTIV2018) is coming and it will be a great occasion for HCS-Pharma to showcase our current co-development, with the institute du thorax of Nantes and the RHU Read more…
As shown by AstraZeneca in Nature reviews*, one third of the safety failures is linked to CNS toxicity during the clinical trials of drugs. Therefore, relevant in vitro human models are needed to detect early Read more…
Come and discover our programs on iPS and 3D culture
3D culture, patients derived culture as iPS, phenotypic screening, machine learning to go to personalized medicine ...
Your children came back to school ? It is the same for Meryl Roudaut who also just begin his PhD training
Using iPS, researchers are moving very quickly in understanding cell differentiation and already manage to recreate a mini-organ in vitro after 20-30 days of differentiation
To incresase the relevance of the early stage of drug research process, using patient derived-cells is really the good way. This can be now feasible by using iPSCs.